Company / Assets per Share
Dianthus Therapeutics, Inc. /DE/ Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$17.06
FY2025
5-year range
$3.46 / $95.07
FY2021-FY2025
Trend
-32.4%
vs FY2024
Sector context
#64 of 210
Health Care
What the data says
At $17.06, Dianthus Therapeutics, Inc. /DE/'s assets per share ranks #64 of 210 in the Health Care sector. Assets per Share has declined for 3 consecutive years, from $95.07 in FY2022 to $17.06 in FY2025.
Based on SEC 10-K filings.
17.06 in FY2025 with a 5-year CAGR of +35.9%.
Declined from $34.81 to $17.06 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -43.6%
- 5-Year CAGR
- +35.9%
- 10-Year CAGR
- -
Sector benchmark
#64 of 210 in Health CareTop 30% of 210This company $17.06 Sector average $296.79
▼
-94.3% below sector average
Key checks
Key Insights
- Dianthus Therapeutics, Inc. /DE/'s assets per share has declined for 3 consecutive years.
- In FY2025, assets per share decreased 32.4% year-over-year.
- Ranks #64 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.06 | -32.4% |
| FY2024 | $25.24 | -27.5% |
| FY2023 | $34.81 | -63.4% |
| FY2022 | $95.07 | +2650.3% |
| FY2021 | $3.46 | -6.1% |
| FY2020 | $3.68 | -24.1% |
| FY2019 | $4.85 | -92.8% |
| FY2018 | $66.91 | +128.1% |
| FY2017 | $29.33 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026